Subsequently, images were collected with CLSM (LSM-800, ZEISS, Germany) (DAPI, ex = 405 nm, em = 460 nm, Cy5.5, ex = 673 nm, em = 692 nm)
Retatrutide has not received marketing authorisation from the MHRA or EMA and is only available within regulated clinical trials
10.1016/j.molmet.2019.06.026 81
You may be an ideal candidate for this treatment if you: Struggle with obesity or excessive weight gain Have a body mass index (BMI) of 30 or higher Have at least one weight-related health conditions, like high blood pressure or cholesterol, and a BMI of at least 27 Are comfortable with weekly self-injections To determine if you are the right candidate for GLP-1 medication, contact our medically-based team and schedule a personal consultation
Two murine GSTpi genes are arranged in tandem and are differentially expressed